Heron Therapeutics (HRTX) EBITDA Margin Growth (5y) (2022 - 2026)
Heron Therapeutics (HRTX) EBITDA Margin Growth (5y) (2022 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Heron Therapeutics |
85.57 Mn |
55.60 Mn |
24.07 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
24,012.00 |
| Dec 31, 2025 |
29,637.00 |
| Sep 30, 2025 |
24,742.00 |
| Jun 30, 2025 |
23,564.00 |
| Mar 31, 2025 |
20,736.00 |
| Dec 31, 2024 |
17,406.00 |
| Sep 30, 2024 |
6,429.00 |
| Jun 30, 2024 |
11,105.00 |
| Mar 31, 2024 |
18,983.00 |
| Dec 31, 2023 |
14,069.00 |
| Sep 30, 2023 |
11,435.00 |
| Jun 30, 2023 |
9,126.00 |
| Mar 31, 2023 |
34,157.00 |
| Dec 31, 2022 |
55,566.00 |
| Sep 30, 2022 |
33,036.00 |
| Jun 30, 2022 |
29,866.00 |
| Mar 31, 2022 |
111,370.00 |
